Inhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injury

Respiratory Research

Volumn 5, Issue , 2004, Pages

  Lee, Hui Su ^a   Kim, Hee Jae ^a   Moon, Chang Sook ^a   Chong, Young Hae ^a   Kang, Jihee Lee ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Acute lung injury; ERK; JNK; LPS; NF B

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; GELATINASE B; I KAPPA B; I KAPPA B ALPHA; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; FLAVONOID;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; LEUKOCYTE MIGRATION; LUNG LAVAGE; MALE; NEUTROPHIL; NONHUMAN; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; PNEUMONIA; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; ANTHRACENES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MALE; MAP KINASE SIGNALING SYSTEM; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 20044394273     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1465-9921-5-23     Document Type: Article

References (51)

1. Steinberg KP, Milberg JA, Martin TR, Mnunder RJ, Cockrill BA, Hudson LD: Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 1997, 150:113-122.
2. van den Blink B, Juffermans NP, ten Hove T, Schultz MJ, van Deventer SJ, van der Poll T, Peppelenbosch MP: p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo. J Immunol 2001, 166:582-587.
3. Scherle PA, Jones EA, Favata MF, Daulerio AJ, Covington MB, Nurnberg SA, Magolda RL, Trzaskos JM: Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol 1998, 161:5681-5686.
4. Nick JA, Young SK, Brown KK, Avdi NJ, Arndt PG, Suratt BT, Janes MS, Henson PM, Worthen GS: Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J Immunol 2000, 164:2151-2159.
5. Underwood DC, Osborn RR, Bochnowicz S, Webb EF, Rieman DJ, Lee JC, Romanic AM, Adams JL, Hay DW, Griswold DE: SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol 2000, 279:L895-L902.
6. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW: In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 1996, 157:1630-1637.
7. Nagase H, Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 1999, 274:21491-21494. Review
8. Kubes P: Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 1995, 2:235-244.
9. Kang JL, Lee HW, Lee HS, Pack IS, Chong Y, Castranova V, Koh Y: Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med 2001, 164:2206-2212.
10. Koh Y, Kang JL, Park W, Pack IS, Lee HS, Kim MJ, Lim CM: Inhaled nitric oxide down-regulates intrapulmonary nitric oxide production in lipopolysaccharide-induced acute lung injury. Crit Care Med 2001, 29:1169-1174.
11. Kristof AS, Goldberg P, Laubach V, Hussain SN: A Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1998, 158:1883-1889.
12. Kumar A, Dhawan S, Mukhopadhyay A, Aggarwal BB: Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. FEBS Lett 1999, 462:140-144.
13. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, Abraham E: Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 1996, 24:1285-1292.
14. Kang JL, Lee HW, Lee HS, Pack IS, Castranova V, Koh Y: Time course for inhibition of lipopolysaccharide-induced lung injury by genistein: relationship to alteration in nuclear factor-kappaB activity and inflammatory agents. Crit Care Med 2003, 31:517-524.
15. Carter AB, Knudtson KL, Monick MM, Hunninghake GW: The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression. The role of TATA-binding protein (TBP). J Biol Chem 1999, 274:30858-30863.
16. Bhattacharyya A, Pathak S, Datta S, Chattopadhyay S, Basu J, Kundu M: Mitogen-activated protein kinases and nuclear factor-kappaB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages. Biochem J 2002, 368:121-129.
17. Jacobs AT, Ignarro LJ: Nuclear factor-κB and mitogen-activated protein kinases mediate nitric oxide-enhanced transcriptional expression of interferon-β. J Biol Chem 2003, 278:8018-8027.
18. Shaulian E, Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol 2002, 4:E131-E136.
19. Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
20. Kumar A, Middleton A, Chambers TC, Mehta KD: Differential roles of extracellular signal-regulated kinase-1/2 and p38 (MAPK) in interleukin-1β-and tumor necrosis factor-α-induced low density lipoprotein receptor expression in HepG2 cells. J Biol Chem 1998, 273:15742-15748.
21. Carter AB, Hunninghake GW: A constitutive active MEK → ERK pathway negatively regulates NF-kappa B-dependent gene expression by modulating TATA-binding protein phosphorylation. J Biol Chem 2000, 275:27858-27864.
22. Matthews JS, O'Neill LA: Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1. Cytokine 1999, 11:643-655.
23. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS: c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001, 108:73-81.
24. Lane FC, Mehta JR: In vitro human tumor sensitivity assay using cell counting and sizing. Am Biotechnol Lab 1990, 8:12-27.
25. Castranova VT, Jones MW, Barger A, Afshari , Frazer DJ: Pulmonary responses of guinea pigs to consecutive exposures to cotton dust. In Proceedings of the fourteenth Cotton Dust Research Conference: Memphis Edited by: Jacobs RR, Wakelyn PJ. Domelsmith LN: National Cotton Council; 1990:131-135.
26. Hartree EF: Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 1972, 48:422-427.
27. Sato H, Takahisa T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994, 370:61-65.
28. Gibbs DF, Warner RL, Weiss SJ, Johnson KJ, Varani J: Characterization of matrix mtalloproteinses produced by rat alveolar macrophages. Am J Respir Cell Mol Biol 1999, 20:1136-1144.
29. Booke M, Bradford DW, Hinder F, Nishida K, Biondo NA, Traber LD, Traber DL: Inhaled nitric oxide selectively reduces pulmonary hypertension after ovine smoke inhalation but does not improve oxygenation. J Burn Care Rehabil 1997, 18(1 Pt 1):27-33.
30. Marshall HE, Stamler JS: Exhaled nitric oxide (NO), NO synthase activity, and regulation of nuclear factor (NF)-kappa B. Am J Respir Cell Mol Biol 1999, 21:296-297.
31. Sun SC, Elwood J, Beraud C, Greene WC: Human T-cell leukemia virus type I Tax activation of NF-kappa B/Rel involves phosphorylation and degradation of I kappa B alpha and Rel A (p65)-mediated induction of the c-rel gene. Mol Cell Biol 1994, 14:7377-7384.
32. Deryckere F, Gannon F: A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 1994, 16:405.
33. Dahan S, Busuttil V, Imbert V, Peyron JF, Rampal P, Czerucka D: Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in T84 cells. Infect Immun 2002, 70:2304-2310.
34. Ishii M, Suzuki Y, Takeshita K, Miyao N, Kudo H, Hiraoka R, Nishio K, Sato N, Naoki K, Aoki T, Yamaguchi K: Inhibition of c-Jun NH(2)-terminal kinase activity improves ischemia/reperfusion injury in rat lungs. J Immunol 2004, 172:2569-2577.
35. Morse D, Otterbein LE, Watkins S, Alber S, Zhou Z, Flavell RA, Davis RJ, Choi AMK: Deficiency in the c-Jun NH2-terminal kinase signaling pathway confers susceptibility to hyperoxic lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2003, 285:L250-L257.
36. Lai WC, Zhou M, Shankavaram U, Peng G, Wahl LM: Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Immunol 2003, 170:6244-6249.
37. Zhang X, Shan P, Sasidhar M, Chupp GL, Flavell RA, Choi AMK, Lee PJ: Reactive oxygen species and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase mediate hyperoxia-induced cell death in lung epithelium. Am J Respir Cell Mol Biol 2003, 28:305-315.
38. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, Feuerstein GZ, Thomas H, Maleeff B, Ohlstein EH: Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 2000, 86:692-699.
39. Ishizuka S, Yano T, Hagiwara K, Sone M, Nihei H, Ozasa H, Horikawa S: Extracellular signal-regulated kinase mediates renal regeneration in rats with myoglobinuric acute renal injury. Biochem Biophys Res Commun 1999, 254:88-92.
40. Kang JL, Park W, Pack IS, Lee HS, Kim MJ, Lim CM, Koh Y: Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-κB and inflammation. J Appl Physiol 2002, 92:795-801.
41. Sacks M, Gordon J, Bylander J, Porter D, Shi XL, Castranova V, Kaczmarczyk W, Vandyke K, Reasor MJ: Silica-induced pulmonary inflammation in rats: activation of NF-kappa B and its suppression by dexamethasone. Biochem Biophys Res Commun 1998, 253:181-184.
42. Schmitz ML, Stelzer G, Altmann H, Meisterernst M, Baeuerle PA: Interaction of the COOH-terminal Transactivation Domain of p65 NF-κB with TATA-binding Protein, Transcription Factor IIB, and Coactivators. J Biol Chem 1995, 270:7219-7226.
43. Christman JW, Sadikot RT, Blackwell TS: The role of nuclear factor-κB in pulmonary diseases. Chest 2000, 117:1482-1487.
44. Carter AB, Monick MM, Hunninghake GW: Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 1999, 20:751-758.
45. Korus M, Mahon GM, Cheng L, Whitehead IP: p38 MAPK-mediated activation of NF-kappaB by the RhoGEF domain of Bcr. Oncogene 2002, 21:44601-4612.
46. Leonardi A, Chariot A, Claudio E, Cunningham K, Siebenlist U: CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc Natl Acad Sci U S A 2000, 97:10494-10499.
47. Funakoshi M, Tago K, Sonoda Y, Tominago S, Kasahara T: A MEK inhibitor, PD98059 enhances IL-1-induced NF-κB activation by the enhanced and sustained degradation of IκB-α. Biochem Biophys Res Commun 2001, 283:248-254.
48. Briant L, Robert-Hermann V, Sivan V, Brunet A, Pouysségur, Devaux C: Involvement of extracellular signal-regulated kinase module in HIV-mediated CD4 signals controlling activation of nuclear factor-κB and AP-1 transcription factors. J Immunol 1998, 160:1875-1885.
49. Chen F, Demers LM, Vallyathan V, Ding M, Lu Y, Castranova V, Shi X: Vanadate induction of NF-kappa B involves I kappa B kinase beta and SAPK/ERK kinase 1 in macrophages. J Biol Chem 1999, 274:20307-20312.
50. Dhawan P, Richmond A: A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. J Biol Chem 2002, 277:7920-7928.
51. Koch A, Giembycz M, Kazuhiro I, Lim S, Jazrawi E, Barnes PJ, Adcock I: Mitogen-activated protein kinase modulation of nuclear factor-κB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages. Am J Respir Cell Mol Biol 2004, 30:342-349.